Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Slideshows|September 1, 2018
Head and Shoulder Lesions: Common Diseases, Uncommon Locations
Author(s)Robert P. Blereau, MD
Three cases of lesions often seen in primary care, 2 seen in uncommon locations. Test your visual diagnostic skills.
Advertisement
Typical lesions of common diseases sometimes present first in atypical locations, making early diagnosis more challenging. Which of these 3 cases prove that observation true?Â
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
2
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
3
ACCORD Trials: Efficacy and Safety of Dextromethorphan-Bupropion in Agitation
4
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
5